This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently menti…
This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently menti…
This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently menti…
Over the course of the twentieth century, the pharmaceutical industry evolved into its modern form. Individual pharmaceutical companies formed trade organizations in the early 1900s and experienced exponential growth in the 1930s and onward with the development of lifesaving and…
Local firms producing prescription drugs for their domestic markets can be a resource for national health systems, but the range and quality of their products is constrained or encouraged by a complex structure of regulation that operates in different ways at the national and in…
This thesis analyzes the implications of the WTO-TRIPS Agreement for the pharmaceutical industry and public health sector in Egypt using a national system of innovation (NSI) approach. My main arguments are (i) that there is no robust method for determining the appropriate balan…
A double case study applying action research methodology was conducted in two pharmaceutical preparation manufacturers in the Netherlands to improve their manufacturing systems by implementing time-based manufacturing (TBM) practices. Following the diagnosis phase, the situation…
China has become the second largest pharmaceutical market since 2014 and its industry is highlighted as the most attractive in the emerging countries. However, its specialities are rooted in historic reasons and the current dynamic situation in addition to the uniqueness of the …
The main purpose of the research was to examine the process of lobbying in the context of the pharmaceutical industry. It sought to explore "why" and "how" multinational companies carried out pharmaceutical lobbying in Argentina. The study aimed to build valid substantive theory…
When speciality chemicals are manufactured within the pharmaceutical industry, they are often produced in stirred batch/semi-batch reactors. A ‘methodology’ was explored, to help with the development of continuous fixed-bed catalytic reactors for this sector. This was tested on …
The outcome of joining the WTO and implementing TRIPS agreement has caused a never-ending dispute in terms of both positive and negative perspectives. Patient's access to essential medicines and sustainability of the domestic pharmaceutical industry are two important relevant to…
‘‘Menopause . . . is the quintessential biopsychosocial experience. It is both crisis and opportunity”. McQuaide (1996:132) This study explores how women in contemporary Ireland understand, experience, and negotiate menopause. The research examines how the Midlife Women Rock Caf…
The pharmaceutical industry, long thought of as a recession-proof investment, now faces a day of reckoning. The reasons for this impending downfall are not hard to discern. The prices the industry charges for its prescription drugs have escalated at four to five times the cost-o…
"The global pharmaceuticals market generated $934.8 billion revenue in 2017 and forecasters predict 5.8% annual growth for the sector through 2021. In the U.S. alone, national health expenditures on medications are forecast to reach $605 billion in 2026; the pharma audit and dat…
"The global pharmaceuticals market generated $934.8 billion revenue in 2017 and forecasters predict 5.8% annual growth for the sector through 2021. In the U.S. alone, national health expenditures on medications are forecast to reach $605 billion in 2026; the pharma audit and dat…
"The global pharmaceuticals market generated $934.8 billion revenue in 2017 and forecasters predict 5.8% annual growth for the sector through 2021. In the U.S. alone, national health expenditures on medications are forecast to reach $605 billion in 2026; the pharma audit and dat…
Intervening into fields including posthumanist, disability, animal and feminist studies, and current critiques of capitalism and consumerism, Frida Beckman explores the possibility of recovering a theory of sexuality from Deleuze's work. She thereby makes a definitive contributi…
